PMID: 9159151May 27, 1997Paper

Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1

Proceedings of the National Academy of Sciences of the United States of America
Vidadi YusibovH Koprowski

Abstract

The coat protein (CP) of alfalfa mosaic virus was used as a carrier molecule to express antigenic peptides from rabies virus and HIV. The antigens were separately cloned into the reading frame of alfalfa mosaic virus CP and placed under the control of the subgenomic promoter of tobacco mosaic virus CP in the 30BRz vector. The in vitro transcripts of recombinant virus with sequences encoding the antigenic peptides were synthesized from DNA constructs and used to inoculate tobacco plants. The plant-produced protein (virus particles) was purified and used for immunization of mice. Both antigens elicited specific virus-neutralizing antibodies in immunized mice.

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H S MasonC J Arntzen
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J DonsonW O Dawson
Mar 3, 1988·Nature·K L BurkeJ W Almond
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·V Yusibov, L S Loesch-Fries
Apr 1, 1993·The Journal of General Virology·R A MasticoP G Stockley
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·D C HooperB Dietzschold
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·B WangD B Weiner
Sep 1, 1995·AIDS Research and Human Retroviruses·S D RencherJ L Hurwitz
May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·H S MasonC J Arntzen
Dec 1, 1995·Bio/technology·P B McGarveyF H Michaels

❮ Previous
Next ❯

Citations

Jul 30, 2005·Journal of Biosciences·Hakan Ozdener
Mar 1, 2013·Applied Microbiology and Biotechnology·Zheng-jun GuanYa-hui Wei
Feb 14, 2008·Plant Cell Reports·Irene Perea ArangoMiguel Angel Gómez Lim
Dec 14, 2011·Plant Cell Reports·Sergio Rosales-MendozaLeticia Moreno-Fierros
May 4, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W W J van de SandeA G Vonk
May 30, 2009·Transgenic Research·Edith Rojas-AnayaMiguel Gomez-Lim
Nov 30, 2000·Current Infectious Disease Reports·J Yu, W H Langridge
Sep 17, 2009·Immunologic Research·Yasmin Thanavala, Amit A Lugade
Jun 10, 2009·Molecular Biotechnology·Eun-Ah ShinJin-Yong Lee
Jun 5, 2003·International Journal for Parasitology·Stephen J Streatfield, John A Howard
Dec 5, 1998·Journal of Immunological Methods·T VerchH Koprowski
Jun 6, 2000·Advanced Drug Delivery Reviews·T L Bowersock, S Martin
Mar 21, 2001·Vaccine·H Koprowski, V Yusibov
Oct 11, 2003·Biotechnology Advances·S R Rao, G A Ravishankar
Feb 7, 2001·Current Opinion in Biotechnology·A M Walmsley, C J Arntzen
Apr 21, 1999·Current Opinion in Biotechnology·K Herbers, U Sonnewald
Jun 15, 1999·Trends in Plant Science·G Hansen, M S Wright
Sep 6, 2000·The Plant Journal : for Cell and Molecular Biology·I R ChoiR French
Sep 18, 2001·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·K OhyaC Sugimoto
May 29, 2002·Hybridoma and Hybridomics·Andreas R Kammer, Hildegund C J Ertl
Apr 23, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·T H Turpen
May 10, 2005·Immunology and Cell Biology·M Carmen CañizaresGeorge P Lomonossoff
May 10, 2005·Immunology and Cell Biology·Diane E WebsterSteve L Wesselingh
Nov 20, 2002·Journal of Virology·M Rosario Fernández-FernándezJuan Antonio García
Jul 31, 2002·Annual Review of Phytopathology·Gregory P PogueWayne P Fitzmaurice
Jun 25, 2008·BMC Biotechnology·Ann MeyersEdward P Rybicki
Nov 24, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·E Hansen, C G Kawashima
Sep 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Nobuyuki MatobaTsafrir S Mor
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·A ModelskaV Yusibov
Jun 18, 2014·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Zenon Steplewski, Thomas Kieber-Emmons
Jul 5, 2005·Expert Opinion on Investigational Drugs·P B RodgersJ R Adair
Mar 11, 2005·Expert Opinion on Emerging Drugs·Richard M TwymanRainer Fischer
Jun 19, 2004·Journal of Drug Targeting·Michael E HornStephen J Streatfield
Nov 22, 2005·Expert Opinion on Drug Delivery·Stephen J Streatfield
Jan 20, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Karin L LeeNicole F Steinmetz
Jan 31, 2012·Plant Science : an International Journal of Experimental Plant Biology·Erin EgelkroutJohn A Howard
Oct 1, 2011·Biotechnology Advances·Parvaiz AhmadF Al-Qurainy
Apr 10, 2009·Biotechnology Advances·Siddharth TiwariRakesh Tuli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.